Cargando…

LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer

BACKGROUND: Ovarian cancer has one of the highest mortality rates among all gynaecological malignancies, and increasing evidence suggests that lncRNAs are widely involved in the development of ovarian tumours. This study aimed to investigate the mechanism of the LNC00115/miR-7/ERK axis in the cispla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xinyan, Cheng, Yan, He, Yanan, Cong, Shanshan, Sun, Liyuan, Wu, Di, Wu, Han, Zhang, Guangmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123956/ https://www.ncbi.nlm.nih.gov/pubmed/34007214 http://dx.doi.org/10.2147/CMAR.S295097

Ejemplares similares

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
por: Wu, Han, et al.
Publicado: (2022)

Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR‐7
por: Yuan, Chunlei, et al.
Publicado: (2020)

LncRNA MALAT1 Accelerates Cervical Carcinoma Proliferation by Suppressing miR-124 Expression in Cervical Tumor Cells
por: Liang, Tian, et al.
Publicado: (2021)

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
por: Wang, Yanan, et al.
Publicado: (2018)

Identification of potential prognostic TF‐associated lncRNAs for predicting survival in ovarian cancer
por: Guo, Qiuyan, et al.
Publicado: (2018)

Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
por: Guo, Qiuyan, et al.
Publicado: (2015)

Down‐regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR‐212‐5p/FZD5/Wnt/β‐catenin axis
por: Peng, Naixiong, et al.
Publicado: (2021)

Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway
por: Feng, Weiyu, et al.
Publicado: (2020)

Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro
por: Shao, Lili, et al.
Publicado: (2021)

lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
por: Li, Zewu, et al.
Publicado: (2019)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

LncRNA LEF1-AS1 Promotes Ovarian Cancer Development Through Interacting with miR-1285-3p
por: Zhang, Yanan, et al.
Publicado: (2020)

miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
por: Dou, Lei, et al.
Publicado: (2021)

LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA
por: Ding, Yi, et al.
Publicado: (2021)

miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases
por: Liu, Jue, et al.
Publicado: (2019)

Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling
por: Tan, Wen-Xi, et al.
Publicado: (2020)

LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
por: Wu, Yue, et al.
Publicado: (2021)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
por: Zhao, Henan, et al.
Publicado: (2016)

MiR-27a-3p Regulated the Aggressive Phenotypes of Cervical Cancer by Targeting FBXW7
por: Ben, Wei, et al.
Publicado: (2020)

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
por: Li, Ningwei, et al.
Publicado: (2015)

Epidrug Modulated Expression of MiR-152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study
por: Khajehnoori, Sahel, et al.
Publicado: (2020)

LncRNA HOTAIR controls the expression of Rab22a by sponging miR-373 in ovarian cancer
por: Zhang, Zhongbao, et al.
Publicado: (2016)

Correction to: LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
por: Wu, Yue, et al.
Publicado: (2023)

Effects of the Wenyang Zhenshuai Granule on the Expression of LncRNA-MiR143HG/miR-143 Regulating ERK5 in H9C2 Cardiomyocytes
por: Xu, Zelin, et al.
Publicado: (2021)

miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
por: Cui, Yajie, et al.
Publicado: (2018)

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
por: Chen, Ying, et al.
Publicado: (2018)

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
por: Feng, Xue, et al.
Publicado: (2017)

STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance
por: Jin, Pengfei, et al.
Publicado: (2018)

miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
por: Yang, Shiying, et al.
Publicado: (2020)

HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
por: Dong, Yu-Jie, et al.
Publicado: (2021)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
por: Quintanilha, Julia C. F., et al.
Publicado: (2021)

LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer
por: Luo, Hua, et al.
Publicado: (2021)

lncRNA TUSC7 sponges miR-10a-5p and inhibits BDNF/ERK pathway to suppress glioma cell proliferation and migration
por: Wang, Runhui, et al.
Publicado: (2023)

LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer
por: Yin, Feng, et al.
Publicado: (2020)

Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
por: Cheng, Yi, et al.
Publicado: (2019)

LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
por: Wu, Liping, et al.
Publicado: (2020)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3
por: Zhao, Shanshan, et al.
Publicado: (2020)

ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells
por: Zhao, Lifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q0796miqietlfhloe83rqn04nm